These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 5302303)

  • 21. Construction of novel vaccine strains of Vibrio cholerae co-expressing the Inaba and Ogawa serotype antigens.
    Lebens M; Karlsson SL; Källgård S; Blomquist M; Ekman A; Nygren E; Holmgren J
    Vaccine; 2011 Oct; 29(43):7505-13. PubMed ID: 21807059
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Type-specific action of vibriocidal antibody on Vibrio cholerae.
    Pykett AH; Preston NW
    J Hyg (Lond); 1975 Dec; 75(3):399-406. PubMed ID: 1059707
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The use of immunoenzyme analysis and the vibriocidal antibody reaction in the serological examination of persons who have had cholera and of those in contact with them].
    Mareev VI; Moskvitina EA; Gritsenko AN; Ivanova LV; Efanova EA; Nepomniashchaia NB; Dranov IIu; Boldyr' LA; Griseva LN
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Feb; (2):34-6. PubMed ID: 1867031
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Report of the 1966-67 cholera vaccine field trial in rural East Pakistan. 3. The lack of effect of prior vaccination or circulating vibriocidal antibody on the severity of clinical cholera.
    McCormack WM; Rahman AS; Chowdhury AK; Mosley WH; Phillips RA
    Bull World Health Organ; 1969; 40(2):199-204. PubMed ID: 5306540
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cholera vaccine field trials in east Pakistan. 2. Effectiveness in the field.
    Benenson AS; Mosley WH; Fahimuddin M; Oseasohn RO
    Bull World Health Organ; 1968; 38(3):359-72. PubMed ID: 5302329
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cholera vaccine field trials in east Pakistan. 1. Reaction and antigenicity studies.
    Benenson AS; Joseph PR; Oseasohn RO
    Bull World Health Organ; 1968; 38(3):347-57. PubMed ID: 5302328
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification and treatment with a long-acting sulphonamide of 15 carriers of Vibrio cholerae El Tor serotype Ogawa, during the 1973 cholera epidemic in Naples.
    De Lorenzo F; Buogo A; Soscia M; Schisa C
    Chemotherapy; 1977; 23(5):345-55. PubMed ID: 332466
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Field trials of monovalent Ogawa and Inaba cholera vaccines in rural Bangladesh--three years of observation.
    Mosley WH; Aziz KM; Rahman AS; Chowdhury AK; Ahmed A
    Bull World Health Organ; 1973; 49(4):381-7. PubMed ID: 4604478
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthetic fragments of Vibrio cholerae O1 Inaba O-specific polysaccharide bound to a protein carrier are immunogenic in mice but do not induce protective antibodies.
    Meeks MD; Saksena R; Ma X; Wade TK; Taylor RK; Kovác P; Wade WF
    Infect Immun; 2004 Jul; 72(7):4090-101. PubMed ID: 15213154
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and immunogenicity study of a killed bivalent (O1 and O139) whole-cell oral cholera vaccine Shanchol, in Bangladeshi adults and children as young as 1 year of age.
    Saha A; Chowdhury MI; Khanam F; Bhuiyan MS; Chowdhury F; Khan AI; Khan IA; Clemens J; Ali M; Cravioto A; Qadri F
    Vaccine; 2011 Oct; 29(46):8285-92. PubMed ID: 21907255
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emergence of Vibrio cholerae O1 biotype El Tor serotype Inaba causing outbreaks of cholera in Orissa, India.
    Pal BB; Khuntia HK; Samal SK; Das SS; Chhotray GP
    Jpn J Infect Dis; 2006 Aug; 59(4):266-9. PubMed ID: 16936349
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies on cholera carriers.
    Dizon JJ; Fukumi H; Barua D; Valera J; Jayme F; Gomez F; Yamamoto SI; Wake A; Gomez CZ; Takahira Y; Paraan A; Rolda L; Alvero M; Abou-Gareeb AH; Kobari K; Azurin JC
    Bull World Health Organ; 1967; 37(5):737-43. PubMed ID: 5300876
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Texas Star-SR: attenuated "Vibrio cholerae" oral vaccine candidate.
    Levine MM; Black RE; Clements ML; Young CR; Lanata C; Sears S; Honda T; Finkelstein R
    Dev Biol Stand; 1983; 53():59-65. PubMed ID: 6873477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serological response to cholera revaccination in a semi-closed community in Calcutta.
    Sinha R; Deb BC; Ganguly R; De SP; Abou-Gareeb AH; Shrivastava DL
    Bull World Health Organ; 1970; 43(3):407-12. PubMed ID: 5312995
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vibriocidal antibodies induced by Yersinia enterocolitica serotype IX.
    Barua D; Watanabe Y
    J Hyg (Lond); 1972 Mar; 70(1):161-9. PubMed ID: 4501837
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vibriocidal antibody and antibodies to Vibrio cholerae lipopolysaccharide, cell-bound haemagglutinin and toxin in Thai population.
    Chongsa-nguan M; Chaicumpa W; Kalambaheti T; Soejoedi H; Luxananil P; Swasdikosa S; Thanasiri P; Mayurasakorn S
    Southeast Asian J Trop Med Public Health; 1986 Dec; 17(4):558-66. PubMed ID: 3576285
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vibriocidal Titer and Protection From Cholera in Children.
    Ritter AS; Chowdhury F; Franke MF; Becker RL; Bhuiyan TR; Khan AI; Saha NC; Ryan ET; Calderwood SB; LaRocque RC; Harris JB; Qadri F; Weil AA
    Open Forum Infect Dis; 2019 Apr; 6(4):ofz057. PubMed ID: 30997364
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Experimental studies on cholera immunization. 4. The antibody response to formalinized Vibrio cholerae and purified endotoxin with special reference to protective capacity.
    Svennerholm AM
    Int Arch Allergy Appl Immunol; 1975; 49(4):434-52. PubMed ID: 808500
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune responses following killed whole vibrio-B subunit oral cholera vaccine in human volunteers.
    Pitisuttithum P; Migasena S; Suntharasamai P; Supanaranond W; Desakorn V; Prayurahong B
    Southeast Asian J Trop Med Public Health; 1989 Jun; 20(2):201-5. PubMed ID: 2609209
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Supplementation with zinc, but not vitamin A, improves seroconversion to vibriocidal antibody in children given an oral cholera vaccine.
    Albert MJ; Qadri F; Wahed MA; Ahmed T; Rahman AS; Ahmed F; Bhuiyan NA; Zaman K; Baqui AH; Clemens JD; Black RE
    J Infect Dis; 2003 Mar; 187(6):909-13. PubMed ID: 12660937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.